Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers are increasingly being used to support a diagnosis of Alzheimer’s disease (AD). Their clinical utility for differentiating AD from non-AD neurodegenerative dementias, such as dementia with Lewy bodies (DLB) or frontotemporal dementia (FTD), is less we...

全面介紹

Na minha lista:
書目詳細資料
發表在:Alzheimers Res Ther
Main Authors: Paterson, Ross W., Slattery, Catherine F., Poole, Teresa, Nicholas, Jennifer M., Magdalinou, Nadia K., Toombs, Jamie, Chapman, Miles D., Lunn, Michael P., Heslegrave, Amanda J., Foiani, Martha S, Weston, Philip S. J., Keshavan, Ashvini, Rohrer, Jonathan D., Rossor, Martin N., Warren, Jason D., Mummery, Catherine J., Blennow, Kaj, Fox, Nick C., Zetterberg, Henrik, Schott, Jonathan M.
格式: Artigo
語言:Inglês
出版: BioMed Central 2018
主題:
Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861624/
https://ncbi.nlm.nih.gov/pubmed/29558979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0361-3
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍